UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044558
Receipt number R000050901
Scientific Title Commonality of gene mutations in hypopharyngeal and esophageal cancer
Date of disclosure of the study information 2021/06/21
Last modified on 2021/06/16 13:42:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Commonality of gene mutations in hypopharyngeal and esophageal cancer

Acronym

Gene mutations in hypopharyngeal and esophageal cancer

Scientific Title

Commonality of gene mutations in hypopharyngeal and esophageal cancer

Scientific Title:Acronym

Gene mutations in hypopharyngeal and esophageal cancer

Region

Japan


Condition

Condition

double cancer, hypopharyngeal and esophageal cancer

Classification by specialty

Gastrointestinal surgery Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

We comprehensively analyze gene mutations in double cancers of hypopharyngeal squamous cell carcinoma and esophageal squamous cell carcinoma, and examine the commonality of their properties related to tumor growth and infiltration.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Commonality of gene mutation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Double cancers of hypopharynx and esophagus that were treated with radical surgery from January 1, 2010 to December 31, 2020 at Kobe University Hospital and Hyogo Cancer Center.
Surgical pathological specimens are available.
The pathological results of both hypopharyngeal cancer and esophageal cancer are squamous cell carcinoma.

Key exclusion criteria

Patients who offered not to participate in this study based on the published information

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Ken-ichi
Middle name
Last name Nibu

Organization

Kobe University Graduate School of Medicine

Division name

Department of Otolaryngology-Head and Neck Surgery

Zip code

650-0017

Address

7-5-2 Kusunokicho Chuo-ku, Kobe, Hyogo 650-0017 Japan

TEL

078-382-5111

Email

nibu@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Hirotaka
Middle name
Last name Shinomiya

Organization

Kobe University Graduate School of Medicine

Division name

Department of Otolaryngology-Head and Neck Surgery

Zip code

650-0017

Address

7-5-2 Kusunokicho Chuo-ku, Kobe, Hyogo 650-0017 Japan

TEL

078-382-5111

Homepage URL


Email

hshino@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan science and technology agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe Univ. Hosp. Clin Transl Res Center

Address

7-5-2 Kusunokicho Chuo-ku, Kobe, Hyogo 650-0017 Japan

Tel

078-382-6669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 06 Month 21 Day

Date of IRB


Anticipated trial start date

2021 Year 06 Month 21 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 06 Month 16 Day

Last modified on

2021 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name